Trial Profile
Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2019
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Primary headache disorders
- Focus Therapeutic Use
- 05 Jun 2018 Status changed from recruiting to completed.
- 06 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Apr 2018.
- 06 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2018.